You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radiation/Temozolomide

Showing 1 - 25 of 9,011
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Trial in Morgantown (Daratumumab)

Recruiting
  • Glioblastoma
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
Dec 5, 2022

Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

Active, not recruiting
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jan 30, 2023

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Glioblastoma, Gliosarcoma Trial in Houston (drug, radiation, procedure)

Recruiting
  • Glioblastoma
  • Gliosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

Glioblastoma Trial run by the NCI (drug, biological, other)

Completed
  • Glioblastoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 23, 2022

Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV) Trial in Baltimore (Chemotherapy with Temodar.,

Terminated
Has Results
  • Histologically Proven Diagnosis of Glioblastoma or Gliosarcoma (WHO Grade IV)
  • Chemotherapy with Temodar.
  • Radiation therapy
  • Baltimore, Maryland
    Ummc Msgcc
Dec 1, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 22, 2022

Gliosarcoma, Newly Diagnosed, Glioblastoma Trial run by the National Cancer Institute (NCI) (Selinexor, Temozolomide, Generic

Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 7, 2022

Newly Diagnosed Glioblastoma Multiforme Trial in Los Angeles (Lapatinib/Temozolomide/radiation)

Active, not recruiting
  • Newly Diagnosed Glioblastoma Multiforme
  • Lapatinib/Temozolomide/radiation
  • Los Angeles, California
    UCLA
Jan 5, 2022

Chemo-radiation Induced Nausea and Vomiting Trial in Durham (Rolapitant, Ondansetron)

Completed
  • Chemo-radiation Induced Nausea and Vomiting
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Dec 12, 2022

Glioblastoma, IDH-wildtype Trial in France, Italy (Metformin, Radiation IMRT, Temozolomide)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Suresnes, Hauts De Seine, France
  • +5 more
Aug 2, 2022

Glioblastoma Trial in Boston (Temozolomide, Bavituximab, Radiation)

Active, not recruiting
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Rhabdomyosarcoma Trial in Palo Alto, Memphis, Fort Worth (Vincristine, Dactinomycin, Cyclophosphamide)

Not yet recruiting
  • Rhabdomyosarcoma
  • Palo Alto, California
  • +2 more
Aug 27, 2023

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

Withdrawn
  • MGMT-Methylated Glioblastoma
  • Delay of TMZ
  • Standard of Care (SOC) Adjuvant TMZ (no intervention
  • (no location specified)
Aug 5, 2022

High Grade Glioma Trial in Cleveland (procedure, radiation, drug)

Recruiting
  • High Grade Glioma
  • LITT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 5, 2023

Glioblastoma Trial in Milwaukee (Radiation, Concurrent Chemotherapy (Temozolomide), Adjuvant Chemotherapy (Temozolomide))

Recruiting
  • Glioblastoma
  • Radiation
  • +2 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Jul 25, 2022

Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

Active, not recruiting
  • Astrocytoma, IDH-Mutant, Grade 2
  • Astrocytoma, IDH-Mutant, Grade 3
  • Questionnaire Administration
  • +3 more
  • Phoenix, Arizona
  • +24 more
Dec 7, 2022

Glioblastoma Trial in Pittsburgh (Radiation Therapy, Temozolomide Oral Product)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • Temozolomide Oral Product
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center, Radiation Oncology
Jan 6, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Astrocytoma, Glioblastoma, Glioblastoma, IDH-Wildtype Trial in Chicago (drug, other, radiation)

Recruiting
  • Astrocytoma
  • +4 more
  • Mycophenolate Mofetil
  • +3 more
  • Chicago, Illinois
    Northwestern University
Aug 22, 2022

Glioblastoma Trial (Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide))

Not yet recruiting
  • Glioblastoma
  • Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)
  • (no location specified)
Apr 20, 2022